Year 1, 2, 3 on the weekly injection. When do you plan to stop? And if you do — will the weight come back? We specialise in cessation.
Three clinical steps to taper safely: the book (995 SEK) teaches you to read your own metabolic markers; the investigation (45,000 SEK) measures your baseline; the clinic guides the actual taper, marker-by-marker. Not a calendar. Data.
First edition. The first 500 copies fund the print run.
GLP-1 medications like Ozempic, Wegovy and Mounjaro. Supplements. Training plans. Nutrition coaching. Weight clubs and diets. Attempts to eat differently. Per year: 25 000–60 000 SEK. Often more than your private pension costs.
Verified Swedish pharmacy list prices from FASS.se (February 2026), cross-referenced with Viktenheten, Fitfika and Pris-Sverige. Prescription and consultation fees added (1 000–2 000 SEK per 3–6 months). GLP-1 for obesity is not covered by Swedish high-cost protection — full out-of-pocket. On discontinuation, weight returns within 6–12 months according to STEP-1 (NEJM 2022) — meaning lifelong treatment for sustained effect.
When my daughter Emilia was five, she nearly died from diabetic ketoacidosis. That day I decided to never accept “within normal limits” again. Eleven years later — this book, Within Normal Limits, is the result.
Your labs come back. Cholesterol is "normal". Blood glucose is "normal". And years later — without warning — you have type 2 diabetes. Or metabolic syndrome. Or you weigh 30 kilos more than when you started.
How does something "normal" become disease without warning?
This is where the book begins. "Within Normal Limits" is not about dieting. It is about reading your labs before the system says "too late". It is about insulin, insulin resistance, and why your body does what it does.
It is about questioning — the way I did when I saw my daughter.
Epistemology is the study of how knowledge is built — from the Greek episteme. By studying the research, the people behind the experiments, and the era they lived in, you gain insights into science and clinical practice you can apply immediately, within the same chapter, to your own health.
We have used over one billion tokens of AI capacity to research, synthesise, and audit the key discoveries underlying what we know and use in metabolic health today. With AI as a research instrument, for the first time it has become possible to do this in a single book — and show you how to put it to use tomorrow.
200 pages · 20 pages a day · 10 days
You will not see the world the same way after.
The book is finished. It is with the editor and ships within 90 days. We are printing 1,000 copies as a special edition. When they're gone, they're gone.
Each Special Edition has a unique ID and QR code granting access to an exclusive digital interpretation service — launching 1 June. Your book is your key.
Michel is founder of Proaktiv Hälsa in Stockholm, where he works with metabolic health and insulin resistance. Over 20 years he has worked with thousands of patients and seen the same pattern: the system does not know how to read a path into disease.
It began when his daughter was diagnosed with type 1 diabetes at age five. But it became real when she weighed 115 kilos at a clinic — and everyone said it was normal. He questioned. He read. He changed her life.
Now he intends to do that questioning on your behalf.
The book is about how to read your labs before they become a diagnosis. It is one clinician's account of questioning the system, and a guide to insulin, insulin resistance, and why the body responds the way it does. It is not a diet book — it is a book about understanding the signals before it is too late.
No. It is a book about metabolic health, insulin, and how to read lab values. It contains no "eat this, avoid that" instructions. It is about understanding what actually happens in the body and how to work with your physician to move through the problem before it becomes a diagnosis.
Pre-order customers receive it first. Delivery before 21 June 2026. You will be notified when it ships.
You enter your details and choose a payment method (card or Klarna where available). You receive immediate confirmation and an email with all details. The first chapter is delivered digitally immediately after purchase.
We accept all major credit cards (Visa, Mastercard, American Express) and Klarna where available. Select your preferred method at checkout.
At purchase: Foreword + introduction + Chapter 1 as PDF, plus the same as audio (English narration).
At launch: The book — Special Edition, delivered before 21 June 2026, with the Lab-Value Lexicon and 10 Questions for Your Physician.
Research shows 50–70 % regain the weight after cessation without structured support (STEP-1, NEJM 2022). It's not willpower. It's metabolic biology. Our method addresses the biology directly.
A 10-day guide to fasting insulin, HOMA-IR, OGTT interpretation. You learn to read your own labs — so you know what drives your weight and what will happen during tapering.
A 4-week metabolic workup. Dynamic OGTT, hormone panel, body composition. We measure what the weekly pen has done — and what remains when you stop. Written report + follow-up clinic visit.
Continuous clinic contact during the taper. We follow your biomarkers and adjust pace individually. This is what no other Swedish clinic offers.
Verified FASS prices (February 2026)
Calculated from official Swedish FASS pharmacy prices — not estimates. Sources below.
| Drug | Start dose /mo | Maintenance /mo | Max dose /mo |
|---|---|---|---|
| Mounjaro (tirzepatide) | ≈ 1,990 SEK 2.5 mg |
≈ 2,700–3,770 SEK 5–10 mg |
≈ 4,820 SEK 12.5–15 mg |
| Wegovy (semaglutide) | ≈ 1,600 SEK 0.25 mg |
≈ 2,500–3,200 SEK 1.7–2.4 mg |
≈ 3,200 SEK 2.4 mg |
| Ozempic (semaglutide) | ≈ 1,049 SEK 0.25 mg |
≈ 1,049 SEK 0.5–1 mg |
≈ 1,049 SEK 1 mg |
Sources: FASS.se (February 2026), Viktenheten, Fitfika, Pris-Sverige. Current as of February 2026, without high-cost protection. Ozempic may be subsidized for approved diabetes indication (TLV); Wegovy is not subsidized. Off-label weight-loss use is not covered by high-cost protection.
At Mounjaro 10 mg maintenance (≈ 3,770 SEK/mo × 10 years) = about 452,000 SEK over 10 years.
Book + investigation, one-time: 45,995 SEK.
Break-even: about 12 months at Mounjaro 10 mg.
20 years of clinical practice in public healthcare and private clinic. Subspecialty: metabolic health, insulin resistance, and pharmacological cessation. Not a motivation coach. A physician.
The weekly pen suppresses hunger. It does not resolve the insulin resistance that drives weight from the beginning. When you stop the pen, the hunger returns — unless the underlying metabolism has been restored. That is what our method does.
We measure fasting insulin, HOMA-IR, OGTT, and body composition before, during, and after taper. Dose reduction proceeds according to what the markers say — not a generic calendar. That is the difference between clinical method and hope.
Clinical capacity is 100 investigations per year. Not for artificial scarcity — because each patient requires continuous marker tracking and clinical follow-up. When the year's slots are filled, they are filled.
Each patient requires continuous marker tracking. By quality standards we don't admit more than we can follow clinically. When the year's slots are full, they are full.
Understand the metabolism. Read your own labs. Then decide whether the investigation is the right next step.
Start with the book →4 weeks of metabolic mapping + clinical follow-up. Baseline for the taper.
Apply for investigation →If the investigation does not identify at least one clinical abnormality or at least one concrete intervention missed by your current care — full refund. It's not motivation that is guaranteed, it's data results.
We specialise in cessation. The book is your map; the clinic is your guide.